Gilead Sciences
GILD
#129
Rank
โ‚น13.512 T
Marketcap
โ‚น10,890
Share price
-1.14%
Change (1 day)
40.82%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น660.20 Billion

According to Gilead Sciences's latest financial reports the company has โ‚น660.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น992.37 B64.11%
2023-12-31โ‚น604.71 B14.45%
2022-12-31โ‚น528.35 B8.87%
2021-12-31โ‚น485.29 B-10.43%
2020-12-31โ‚น541.77 B-68.8%
2019-12-31โ‚น1.736 T-17.46%
2018-12-31โ‚น2.103 T29.17%
2017-12-31โ‚น1.628 T101.51%
2016-12-31โ‚น808.32 B-16.73%
2015-12-31โ‚น970.70 B51.23%
2014-12-31โ‚น641.89 B387.33%
2013-12-31โ‚น131.71 B29.18%
2012-12-31โ‚น101.96 B-80.53%
2011-12-31โ‚น523.72 B456.91%
2010-12-31โ‚น94.04 B22.32%
2009-12-31โ‚น76.88 B-10.64%
2008-12-31โ‚น86.03 B87.07%
2007-12-31โ‚น45.99 B10.85%
2006-12-31โ‚น41.49 B-60.1%
2005-12-31โ‚น103.99 B91.49%
2004-12-31โ‚น54.30 B68.72%
2003-12-31โ‚น32.18 B-28.77%
2002-12-31โ‚น45.19 B60.69%
2001-12-31โ‚น28.12 B17.49%
2000-12-31โ‚น23.93 B87.03%
1999-12-31โ‚น12.79 B197.72%
1998-12-31โ‚น4.29 B241.82%
1997-12-31โ‚น1.25 B-73.5%
1996-12-31โ‚น4.74 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
โ‚น848.50 B 28.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น564.80 B-14.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น509.46 B-22.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น114.81 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น355.78 B-46.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 103.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น1.667 T 152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น890.59 B 34.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.636 T 147.84%๐Ÿ‡บ๐Ÿ‡ธ USA